Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study

Figure 1

Changes in urine albumin/creatinine ratio 1 year before and 1 year after DPP-4i treatment initiation. Changes in urine albumin/creatinine ratio in all patients (a) and in patients with macroalbuminuria (b), microalbuminuria (c), and normoalbuminuria (d). (Data are presented as means with standard errors.) DPP-4i: dipeptidyl-peptidase IV inhibitor; UACR: urine albumin/creatinine ratio. value < 0.05.

(a)

(b)

(c)

(d)